Surfacide, a UV disinfection company’s Surfacide Helios System of UV robots has been enlisted, by a dozen top pediatric hospitals around the country and in the United Kingdom to help protect and keep their young patients and healthcare workers safe during the ongoing pandemic.
Surfacide’s UV-C technology is scientifically proven to inactivate coronavirus-the family of viruses that make up SARS-CoV-2 and COVID-19. Founded in 2010, Surfacide is the world’s first and only patented, automated, multiple-emitter UV-C system to safely eradicate harmful bacteria and viruses from environments. Using three light-emitting robots simultaneously, Surfacide provides UV-C energy to more exposed areas than single emitters—boosting power, dosage and efficacy in as little as 5 minutes.
Gunner Lyslo, Founder and CEO, Surfacide said: “We are grateful that so many pediatric hospitals have adopted Surfacide’s powerful, trusted UV-C robot technology during these critical times. We are proud that Surfacide UV-C is having a positive impact in combating COVID-19 and protecting our most vulnerable young patients and all of the frontline essential healthcare workers that care for them.”
